You are here


Found 19 results

Sort by:[Year][Author]
Filters: keyword is Camels  [Clear All Filters]
2006
DeGenst E, SilenceK, DecanniereK, ConrathK, LorisR, KinneJ, MuyldermansS, WynsL.  2006.  Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. 103(12):4586-4591. Abstract
2005
SaerensD, PellisM, LorisR, PardonE, DumoulinM, MatagneA, WynsL, MuyldermansS, ConrathK.  2005.  Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies. 352(3):597-607. Abstract
ConrathK, VinckeC, StijlemansB, SchymkowitzJ, DecanniereK, WynsL, MuyldermansS, LorisR.  2005.  Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH. 350(1):112-125. Abstract
DeGenst E, SilenceK, GhahroudiMA, DecanniereK, LorisR, KinneJ, WynsL, MuyldermansS.  2005.  Strong in vivo maturation compensates for structurally restricted H3 loops in antibody repertoires. 280(14):14114-14121. Abstract
DumoulinM, CanetD, LastAM, PardonE, ArcherDB, MuyldermansS, WynsL, MatagneA, RobinsonCV, RedfieldC, DobsonCM.  2005.  Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. Nature. 346(3):773-788. Abstract
2004
DeGenst E, HandelbergF, VanMeirhaeghe A, VynckS, LorisR, WynsL, MuyldermansS.  2004.  Chemical basis for the affinity maturation of a camel single domain antibody. 279(51):53593-53601. Abstract
2003
LorisR, MarianovskyI, LahJ, LaeremansT, Engelberg-KulkaH, GlaserG, MuyldermansS, WynsL.  2003.  Crystal structure of the intrinsically flexible addiction antidote MazE. 278(30):28252-28257. Abstract
LahJ, MarianovskyI, GlaserG, Engelberg-KulkaH, KinneJ, WynsL, LorisR.  2003.  Recognition of the intrinsically flexible addiction antidote MazE by a dromedary single domain antibody fragment. Structure, thermodynamics of binding, stability, and influence on interactions with DNA. 278(16):14101-14111. Abstract
2002
DumoulinM, ConrathK, VanMeirhaeghe A, MeersmanF, HeremansK, FrenkenLG, MuyldermansS, WynsL, MatagneA.  2002.  Single-domain antibody fragments with high conformational stability. 11(3):500-515. Abstract
2001
DecanniereK, TransueTR, DesmyterA, MaesD, MuyldermansS, WynsL.  2001.  Degenerate interfaces in antigen-antibody complexes. 313(3):473-478. Abstract
ConrathKE, LauwereysM, GalleniM, MatagneA, FrereJM, KinneJ, WynsL, MuyldermansS.  2001.  Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. 45(10):2807-2812. Abstract
ElsConrath K, LauwereysM, WynsL, MuyldermansS.  2001.  Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. 276(10):7346-7350. Abstract
2000
NguyenVK, HamersR, WynsL, MuyldermansS.  2000.  Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire. 19(5):921-930. Abstract
1999
NguyenVK, HamersR, WynsL, MuyldermansS.  1999.  Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies. 36(8):515-524. Abstract
DecanniereK, DesmyterA, LauwereysM, GhahroudiMA, MuyldermansS, WynsL.  1999.  A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops. 7(4):361-370. Abstract
1998
TransueTR, DeGenst E, GhahroudiMA, WynsL, MuyldermansS.  1998.  Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate. 32(4):515-522. Abstract
LauwereysM, ArbabiGhahroudi M, DesmyterA, KinneJ, HolzerW, DeGenst E, WynsL, MuyldermansS.  1998.  Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. 17(13):3512-3520. Abstract
1997
ArbabiGhahroudi M, DesmyterA, WynsL, HamersR, MuyldermansS.  1997.  Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. 414(3):521-526. Abstract
1996
DesmyterA, TransueTR, GhahroudiMA, ThiMH, PoortmansF, HamersR, MuyldermansS, WynsL.  1996.  Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. 3(9):803-811. Abstract